Introduction
Ischemic stroke, cardioembolic stroke
SECONDARY, ISCHEMIC STROKE
Ischemic stroke remains a significant global health burden, contributing to substantial morbidity and mortality rates [Tirofiban, a glycoprotein IIb/IIIa receptor inhibitor, has gained attention as a potential adjunctive therapy in the context of EVT for cardioembolic stroke [In this secondary analysis of the RESCUE BT trial [